CAMBRIDGE, Mass., March 28, 2023 /PRNewswire/ -- Blueprint Medicines Corporation (BPMC) today announced that the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on the Phase ...

TORONTO, ON / ACCESS Newswire / October 29, 2025 / Jaguar Mining Inc. (TSX:JAG) ("Jaguar" or the "Company") is pleased to announce a significant milestone toward the safe and efficient restart of ...

Toronto, Ontario--(Newsfile Corp. - March 10, 2025) - Roscan Gold Corporation (ROS:CA) (FSE: 2OJ) (OTCQB: RCGCF) ("Roscan" or the "Company") welcomes the announcement by the Government of Mali ...

Larimar Therapeutics, Inc. LRMR announced that the FDA has removed the partial clinical hold on its nomlabofusp (CTI-1601) clinical program following a review of the phase II dose exploration study ...